Technical Analysis for CMPX - Compass Therapeutics Inc

Grade Last Price % Change Price Change
C 5.35 0.00% 0.0000
CMPX closed unchanged on Wednesday, June 16, 2021, on 89 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical CMPX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction 1.90%
Inside Day Range Contraction 1.90%
Older End-of-Day Signals for CMPX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Compass Therapeutics, Inc., a clinical-stage biotechnology company, develops and discovers antibody therapeutics for treating solid tumors and hematological malignancies in the United States. The company's lead product candidate is CTX-471, a monoclonal antibody agonist of CD137, a co-stimulatory receptor on immune cells that is in Phase 1b clinical trial, as well as in preclinical stage in combination with trastuzumab and/or cetuximab for the treatment of oncology. Its products in preclinical development stage include CTX-8371, a bispecific antibody that targets PD-1 and PD-L1 checkpoint inhibitor antibodies. Compass Therapeutics, Inc. was founded in 2014 and is headquartered in Cambridge, Massachusetts.

Sector: Other
Industry: Other
Keywords: Medicine Biotechnology Medical Specialties Clinical Medicine Immunology Immune System Solid Tumors Antibodies Cancer Immunotherapy Monoclonal Antibody Hematological Malignancies Monoclonal Antibody Therapy Trastuzumab Immune Checkpoint Programmed Cell Death Protein 1

Is CMPX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 11.0
52 Week Low 3.53
Average Volume 9,929
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 4.7430
10-Day Moving Average 5.2600
Average True Range 0.4950
ADX 8.68
+DI 35.7710
-DI 35.4723
Chandelier Exit (Long, 3 ATRs) 4.4350
Chandelier Exit (Short, 3 ATRs) 5.0150
Upper Bollinger Bands 5.9058
Lower Bollinger Band 3.5802
Percent B (%b) 0.76
BandWidth 49.0323
MACD Line -0.1609
MACD Signal Line -0.2639
MACD Histogram 0.1029
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.3800
Resistance 3 (R3) 5.3833 5.3767 5.3750
Resistance 2 (R2) 5.3767 5.3690 5.3750 5.3733
Resistance 1 (R1) 5.3633 5.3643 5.3600 5.3600 5.3717
Pivot Point 5.3567 5.3567 5.3550 5.3550 5.3567
Support 1 (S1) 5.3433 5.3490 5.3400 5.3400 5.3283
Support 2 (S2) 5.3367 5.3443 5.3350 5.3267
Support 3 (S3) 5.3233 5.3367 5.3250
Support 4 (S4) 5.3200